Benatti Luca

Director, Intercept Pharmaceuticals.

Companies

IRulya Therapeutics Inc.Board member Oct 24, 2023 to now¹
Intercept PharmaceuticalsBoard member Jul 18, 2014 to Nov 13, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

IRulya Therapeutics Inc. QNCX39,179 shares³$1.3M at $33.23Dec 26, 2025
Intercept Pharmaceuticals ICPT0 shares⁴Nov 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 26, 2025Sold 50,000 shares at $3.47 of IRulya Therapeutics Inc.³
Oct 23, 2024Other 8,918 shares of IRulya Therapeutics Inc.⁵
Nov 8, 2023Returned to company 8,111 shares at $19.00 of Intercept Pharmaceuticals⁴
Nov 8, 2023U 25,487 shares at $19.00 of Intercept Pharmaceuticals⁴
May 24, 2023Granted 8,111 shares of Intercept Pharmaceuticals⁶
May 25, 2022Granted 7,737 shares of Intercept Pharmaceuticals⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIRulya Therapeutics Inc., Board member
2
SEC EDGARIntercept Pharmaceuticals, Board member
3
SEC EDGARIRulya Therapeutics Inc. shares after the filing of Dec 26, 2025
4
SEC EDGARIntercept Pharmaceuticals shares after the filing of Nov 8, 2023
5
SEC EDGARForm 4 filed Dec 29, 2025
6
SEC EDGARForm 4 filed May 25, 2023
7
SEC EDGARForm 4 filed May 27, 2022